Cardiac biomarkers in heart failure

被引：46

作者：

Liquori, Michael E. ^{[1
]}

Christenson, Robert H. ^{[2
]}

Collinson, Paul O. ^{[3
]}

deFilippi, Christopher R. ^{[4
]}

机构：

[1] Univ Maryland, Sch Med, Dept Internal Med, Baltimore, MD 21201 USA

[2] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA

[3] Univ London St Georges Hosp, London SW17 0QT, England

[4] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA

来源：

CLINICAL BIOCHEMISTRY | 2014年 / 47卷 / 06期

关键词：

Heart failure; Biomarkers; Cardiac; Troponin; Natriuretic peptide; C-REACTIVE-PROTEIN; BRAIN NATRIURETIC PEPTIDE; GROWTH-DIFFERENTIATION FACTOR-15; MIDREGIONAL PRO-ADRENOMEDULLIN; RECEPTOR FAMILY-MEMBER; TUMOR-NECROSIS-FACTOR; TERMINAL PROVASOPRESSIN COPEPTIN; PLASMA MYELOPEROXIDASE LEVELS; LEFT-VENTRICULAR DYSFUNCTION; HIGH-SENSITIVITY TROPONIN;

D O I：

10.1016/j.clinbiochem.2014.01.032

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Background: Heart failure is a syndrome characterized by the inability of the heart to meet the body's circulatory demands. Heart failure is a growing health issue worldwide and the prevalence of heart failure is expected to rise as populations age. Therapies and interventions for a variety of cardiac conditions continue to advance and biomarkers will play an increasing role in patient management. Methods: This is a review of the clinical research in blood based biomarkers for diagnosis, prognosis and therapeutic guidance of heart failure. The focus of this review is biomarkers that are currently available for clinical measurement, and their current and potential for applications for managing heart failure patients. Results: The various biologic pathways and physiologic processes of heart failure biomarkers represent a host of different including inflammation, remodeling, strain, neurohormonal activation, metabolism and cardiac myocyte injury. The clinical characteristics and applications of each heart failure biomarker are discussed. Conclusion: As populations age and effective treatments and interventions for coronary artery disease improve, heart failure will increase in incidence and prevalence. Blood biomarkers will play an increasing role in the early diagnosis, therapeutic monitoring and management of heart failure patients in the future. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：327 / 337

页数：11

共 151 条

[91] INCREASED PLASMA-LEVELS OF ADRENOMEDULLIN IN PATIENTS WITH HEART-FAILURE [J].

NISHIKIMI, T ;

SAITO, Y ;

KITAMURA, K ;

ISHIMITSU, T ;

ETO, T ;

KANGAWA, K ;

MATSUO, H ;

OMAE, T ;

MATSUOKA, H .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (06) :1424-1431

[92] Cardiac troponin T vs other biochemical markers in patients with congestive heart failure [J].

Nishio, Yukiko ;

Sato, Yukihito ;

Taniguchi, Ryoji ;

Shizuta, Satoshi ;

Doi, Takahiro ;

Morimoto, Takeshi ;

Kimura, Takeshi ;

Kita, Toru .

CIRCULATION JOURNAL, 2007, 71 (05) :631-635

[93] Trends in prevalence and outcome of heart failure with preserved ejection fraction [J].

Owan, Theophilus E. ;

Hodge, David O. ;

Herges, Regina M. ;

Jacobsen, Steven J. ;

Roger, Veronique L. ;

Redfield, Margaret M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03) :251-259

[94] Cardiac troponin I as prognostic marker in heart failure patients discharged from emergency department [J].

Parenti, Nicola ;

Bartolacci, Silvia ;

Carle, Flavia ;

Angelo, Fanciulli .

INTERNAL AND EMERGENCY MEDICINE, 2008, 3 (01) :43-47

[95] Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure [J].

Pascual-Figal, Domingo A. ;

Manzano-Fernandez, Sergio ;

Boronat, Miguel ;

Casas, Teresa ;

Garrido, Iris P. ;

Bonaque, Juan C. ;

Pastor-Perez, Francisco ;

Valdes, Mariano ;

Januzzi, James L. .

EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (07) :718-725

[96] Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction [J].

Pascual-Figal, Domingo A. ;

Ordonez-Llanos, Jordi ;

Tornel, Pedro L. ;

Vazquez, Rafael ;

Puig, Teresa ;

Valdes, Mariano ;

Cinca, Juan ;

Bayes de Luna, Antoni ;

Bayes-Genis, Antoni .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (23) :2174-2179

[97] Cardiac troponin and outcome in acute heart failure [J].

Peacock, W. Frank ;

De Marco, Teresa ;

Fonarow, Gregg C. ;

Diercks, Deborah ;

Wynne, Janet ;

Apple, Fred S. ;

Wu, Alan H. B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) :2117-2126

[98] Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study [J].

Potocki, Mihael ;

Breidthardt, Tobias ;

Reichlin, Tobias ;

Morgenthaler, Nils G. ;

Bergmann, Andreas ;

Noveanu, Markus ;

Schaub, Nora ;

Uthoff, Heiko ;

Freidank, Heike ;

Buser, Lorenz ;

Bingisser, Roland ;

Christ, Michael ;

Mebazaa, Alexandre ;

Mueller, Christian .

CRITICAL CARE, 2009, 13 (04)

[99] Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction [J].

Poulsen, SH ;

Host, NB ;

Jensen, SE ;

Egstrup, K .

CIRCULATION, 2000, 101 (13) :1527-1532

[100]

Rauchhaus M, 2000, CIRCULATION, V102, P3060

← 5 6 7 8 9 10 11 12 13 14 →